Isolation of Cultured Endothelial Progenitor Cells in vitro from PBMCs and CD133~+ Enriched Cells

被引:0
|
作者
郑伟红 [1 ]
万亚峰 [1 ]
马小鹏 [1 ]
李兴睿 [1 ]
杨志芳 [1 ]
殷茜 [1 ]
易继林 [1 ]
机构
[1] Department of General Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology
关键词
endothelial progenitor cells; cell culture; MACS;
D O I
暂无
中图分类号
R329 [人体组织学];
学科分类号
100101 ;
摘要
Two isolation methods for sorting of endothelial progenitor cells(EPCs):from peripheral blood mononuclear cells(PBMCs)and CD133+ enriched cells were compared,by defining the cell morphology,phenotype,reproductive activities and function in vitro,to provide a reference for clinical application of EPCs.PBMCs from healthy subjects were used either directly for cell culture or for CD133+ sorting.The two groups of cells were cultured in complete medium 199(M199)for 7 to 14 days and the phenotypes of EPCs were analyzed by FACS.The proliferation of differentiated EPCs was studied by MTT assay,and the VEGF concentration was measured using an ELISA kit.ECM gel experiment and migration assay were performed in vivo.The results showed that PBMCs produced more colony-forming units(CFU)than CD133+ enriched cells from the same volume of blood(P<0.01).From day 7 to 14,the two groups showed decreased expression of hematopoietic stem cell markers and increased level of endothelial markers,but CD144+ cells in CD133+ group were less than in PBMCs group(P<0.01).PBMCs group secreted more VEGF than CD133+ group on the day 7(P<0.01).As compared with CD133+ group,PBMCs group had more potent potential of proliferation and vascularization in vitro.It was concluded that CD133+ sorted cells showed a lower capacity of differentiation,secretion,proliferation and vascularization in vitro,suggesting that CD133-negative cells may be a preferential way to get EPCs for clinical therapy.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 50 条
  • [21] New Insights into the Renal Progenitor Cells and Kidney Diseases by Studying CD133
    Bussolati, Benedetta
    Camussi, Giovanni
    PROMININ-1 (CD133): NEW INSIGHTS ON STEM & CANCER STEM CELL BIOLOGY, 2013, 777 : 113 - 123
  • [22] CD133 positive progenitor cells are potential biomarkers for pulmonary arterial hypertension
    Foris, V.
    Kovacs, G.
    Marsh, L.
    Balint, Z.
    Toetsch, M.
    Bachmaier, G.
    Ghanim, B.
    Klepetko, W.
    Olschewski, A.
    Olschewski, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (19-20) : 677 - 677
  • [23] CD133 as a putative marker of cancer stem/progenitor cells in hepatocellular carcinoma
    Suetsugu, Atsushi
    Nagaki, Masahito
    Tsukada, Yoshihiko
    Osawa, Yosuke
    Moriwaki, Hisataka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A192 - A192
  • [24] CD133 Positive Progenitor Endothelial Cell Lines from Human Cord Blood
    Paprocka, Maria
    Krawczenko, Agnieszka
    Dus, Danuta
    Kantor, Aneta
    Carreau, Aude
    Grillon, Catherine
    Kieda, Claudine
    CYTOMETRY PART A, 2011, 79A (08) : 594 - 602
  • [25] Differential characteristics of CD133+ and CD133− Jurkat cells
    Azadeh Anbarlou
    Amir Atashi
    Masoud Soleimani
    Mahshid AkhavanRahnama
    Mahbobeh Bohloli
    Majid Mossahebi-Mohammadi
    In Vitro Cellular & Developmental Biology - Animal, 2015, 51 : 556 - 561
  • [26] Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin
    Bhatia, S.
    Reister, S.
    Mahotka, C.
    Meisel, R.
    Borkhardt, A.
    Grinstein, E.
    LEUKEMIA, 2015, 29 (11) : 2208 - 2220
  • [27] Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin
    S Bhatia
    S Reister
    C Mahotka
    R Meisel
    A Borkhardt
    E Grinstein
    Leukemia, 2015, 29 : 2208 - 2220
  • [28] Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
    Rutella, Sergio
    Bonanno, Giuseppina
    Procoli, Annabella
    Mariotti, Andrea
    Corallo, Maria
    Prisco, Maria Grazia
    Eramo, Adriana
    Napoletano, Chiara
    Gallo, Daniela
    Perillo, Alessandro
    Nuti, Marianna
    Pierelli, Luca
    Testa, Ugo
    Scambia, Giovanni
    Ferrandina, Gabriella
    CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4299 - 4311
  • [29] CD133 expression in osteosarcoma and derivation of CD133+ cells
    Li, Ji
    Zhong, Xiao-Yan
    Li, Zong-Yu
    Cai, Jin-Fang
    Zou, Lin
    Li, Jian-Min
    Yang, Tao
    Liu, Wei
    MOLECULAR MEDICINE REPORTS, 2013, 7 (02) : 577 - 584
  • [30] CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
    Wang, Jian
    Sakariassen, Per O.
    Tsinkalovsky, Oleg
    Immervoll, Heike
    Boe, Stig Ove
    Svendsen, Agnete
    Prestegarden, Lars
    Rosland, Gro
    Thorsen, Frits
    Stuhr, Linda
    Molven, Anders
    Bjerkvig, Rolf
    Enger, Per O.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (04) : 761 - 768